Mustufa Jafry
MOHS-Micrographic Surgery · Mill Creek, WANPI 1447888540
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,730, more than ten times the $117 reported in 2021.
Across 63 payments — averaging $68.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$497
- Sanofi$476
- Johnson & Johnson$390
- Dermavant Sciences, Inc.$383
- UCB, Inc.$359
- Amgen$290
- plus $2K from 15 others
What the payments were for
- Food & beverage$4,19398%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $497 |
| Sanofi | 5 | $476 |
| Johnson & Johnson | 5 | $390 |
| Dermavant Sciences, Inc. | 3 | $383 |
| UCB, Inc. | 5 | $359 |
| Amgen | 8 | $290 |
| Galderma Laboratories, L.p. | 3 | $242 |
| Lilly USA, LLC | 2 | $219 |
| Journey Medical Corporation | 2 | $203 |
| Pfizer | 2 | $195 |
| AbbVie | 7 | $169 |
| Sun Pharmaceutical Industries Inc. | 2 | $149 |
| Convatec Inc. | 1 | $140 |
| E.r. Squibb & Sons, L.L.C. | 1 | $133 |
| Genentech USA, Inc. | 1 | $128 |
| Stemline Therapeutics Inc. | 1 | $117 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $90 |
| Incyte Corporation | 2 | $56 |
| Novartis | 1 | $32 |
| Organogenesis Inc. | 1 | $16 |
| Organon | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,293 in reported general payments places this provider in the 80th percentile of 38 mohs-micrographic surgery providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 18 | $65,008 |
| Tacrolimus | 12 | $894 |
| Clindamycin Phosphate | 19 | $843 |
| Ketoconazole | 51 | $837 |
| Triamcinolone Acetonide | 59 | $593 |
| Doxycycline Hyclate | 12 | $523 |
| Clobetasol Propionate | 14 | $299 |
| Hydrocortisone | 37 | $286 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Mill Creek
- Ein Gun SongMill Creek$4.5M
- Joy MakdisiMill Creek$671
- Dieter SchmidtMill Creek$551
- Jeremy PeckRichland$9K
- Marcus TanRenton$8K
- Mikel MuseVancouver$6K
- Jennifer ReichelSeattle$5K
- Kirk EcklundYakima$5K
- John NiaSpokane$5K
- Maureen MooneyUniversity Place$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.